Standard Biotools Stock Buy Hold or Sell Recommendation

LAB Stock  USD 1.14  0.04  3.64%   
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Standard Biotools is 'Strong Sell'. Macroaxis provides Standard Biotools buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LAB positions.
  
Check out Standard Biotools Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.
In addition, we conduct extensive research on individual companies such as Standard and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Execute Standard Biotools Buy or Sell Advice

The Standard recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Standard Biotools. Macroaxis does not own or have any residual interests in Standard Biotools or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Standard Biotools' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Standard BiotoolsBuy Standard Biotools
Strong Sell

Market Performance

Very WeakDetails

Volatility

DangerousDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Responds to the marketDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Not AvailableDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Standard Biotools has a Mean Deviation of 4.13, Standard Deviation of 5.94 and Variance of 35.29
We provide advice to complement the current expert consensus on Standard Biotools. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Standard Biotools is not overpriced, please validate all Standard Biotools fundamentals, including its shares owned by institutions, price to sales, and the relationship between the shares outstanding and price to earning . Given that Standard Biotools is a hitting penny stock territory we recommend to closely look at its number of shares shorted.

Standard Biotools Trading Alerts and Improvement Suggestions

Standard Biotools generated a negative expected return over the last 90 days
Standard Biotools has high historical volatility and very poor performance
Standard Biotools may become a speculative penny stock
The company reported the last year's revenue of 174.43 M. Reported Net Loss for the year was (138.88 M) with profit before taxes, overhead, and interest of 84.26 M.
Standard Biotools has about 81.31 M in cash with (143.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.68, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Standard Biotools has a poor financial position based on the latest SEC disclosures
Roughly 73.0% of the company shares are owned by institutional investors

Standard Biotools Returns Distribution Density

The distribution of Standard Biotools' historical returns is an attempt to chart the uncertainty of Standard Biotools' future price movements. The chart of the probability distribution of Standard Biotools daily returns describes the distribution of returns around its average expected value. We use Standard Biotools price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Standard Biotools returns is essential to provide solid investment advice for Standard Biotools.
Mean Return
-0.86
Value At Risk
-9.29
Potential Upside
6.02
Standard Deviation
5.94
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Standard Biotools historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Standard Biotools Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Standard Biotools or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Standard Biotools' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Standard stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
-1.11
β
Beta against Dow Jones-2.22
σ
Overall volatility
5.94
Ir
Information ratio -0.13

Standard Biotools Volatility Alert

Standard Biotools exhibits very low volatility with skewness of 1.54 and kurtosis of 6.66. Standard Biotools is a potential penny stock. Although Standard Biotools may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Standard Biotools. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Standard instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Standard Biotools Fundamentals Vs Peers

Comparing Standard Biotools' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Standard Biotools' direct or indirect competition across all of the common fundamentals between Standard Biotools and the related equities. This way, we can detect undervalued stocks with similar characteristics as Standard Biotools or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Standard Biotools' fundamental indicators could also be used in its relative valuation, which is a method of valuing Standard Biotools by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Standard Biotools to competition
FundamentalsStandard BiotoolsPeer Average
Return On Equity-0.44-0.31
Return On Asset-0.18-0.14
Profit Margin(0.80) %(1.27) %
Operating Margin(0.29) %(5.51) %
Current Valuation175.96 M16.62 B
Shares Outstanding378.99 M571.82 M
Shares Owned By Insiders1.85 %10.09 %
Shares Owned By Institutions73.11 %39.21 %
Number Of Shares Shorted13.5 M4.71 M
Price To Earning(2.52) X28.72 X
Price To Book0.92 X9.51 X
Price To Sales2.39 X11.42 X
Revenue174.43 M9.43 B
Gross Profit84.26 M27.38 B
EBITDA(175.24 M)3.9 B
Net Income(138.88 M)570.98 M
Cash And Equivalents81.31 M2.7 B
Cash Per Share2.68 X5.01 X
Total Debt33 M5.32 B
Debt To Equity0.38 %48.70 %
Current Ratio5.87 X2.16 X
Book Value Per Share1.23 X1.93 K
Cash Flow From Operations(143.45 M)971.22 M
Short Ratio6.28 X4.00 X
Earnings Per Share(0.52) X3.12 X
Price To Earnings To Growth0.31 X4.89 X
Target Price2.38
Number Of Employees1918.84 K
Beta1.62-0.15
Market Capitalization416.88 M19.03 B
Total Asset612.34 M29.47 B
Retained Earnings(1.19 B)9.33 B
Working Capital309.99 M1.48 B
Note: Disposition of 31031 shares by Michael Egholm of Standard Biotools at 1. subject to Rule 16b-3 [view details]

Standard Biotools Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Standard . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Standard Biotools Buy or Sell Advice

When is the right time to buy or sell Standard Biotools? Buying financial instruments such as Standard Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Standard Biotools in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Growth Funds Thematic Idea Now

Large Growth Funds
Large Growth Funds Theme
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Standard Biotools offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Standard Biotools' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Standard Biotools Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Standard Biotools Stock:
Check out Standard Biotools Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. If investors know Standard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Standard Biotools listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Standard Biotools' value and its price as these two are different measures arrived at by different means. Investors typically determine if Standard Biotools is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Standard Biotools' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.